Porvair (LON:PRV) Sets New 1-Year High – Time to Buy?

Shares of Porvair plc (LON:PRV – Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as GBX 920 and last traded at GBX 870, with a volume of 56,359 shares traded. The stock had previously closed at GBX 906.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Berenberg Bank dropped their target price on Porvair from GBX 1,050 to GBX 1,000 and set a “buy” rating for the company in a report on Thursday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,050 price target on shares of Porvair in a research note on Thursday. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of GBX 1,025.

Get Our Latest Stock Analysis on PRV

Porvair Stock Up 2.9%

The company has a debt-to-equity ratio of 14.49, a current ratio of 1.94 and a quick ratio of 1.22. The company has a market cap of £421.39 million, a P/E ratio of 22.57 and a beta of 0.52. The stock has a 50-day moving average of GBX 871.55 and a 200 day moving average of GBX 818.34.

Porvair Company Profile

(Get Free Report)

Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.

Featured Stories

Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.